|Heart failure| | | |
|Addition of a non–TNF inhibitor bDMARD or tsDMARD is conditionally recommended over addition of a TNF inhibitor for patients with NYHA class III or IV heart failure and an inadequate response to csDMARDs.|Very low|PICO 70|p. 435|
|Switching to a non–TNF inhibitor bDMARD or tsDMARD is conditionally recommended over continuation of a TNF inhibitor for patients taking a TNF inhibitor who develop heart failure.|Very low|PICO 71|p. 436|
|Lymphoproliferative disorder| | | |